Raydiant Oximetry

Raydiant Oximetry

Private
San Ramon, CaliforniaHealthcare & Life Scienceshttps://www.raydiantoximetry.com

Last Round

Grant

Nov 1, 2024

Total Funding Raised

$22.85M

Company Overview

Raydiant Oximetry is a healthcare technology company that develops a non-invasive medical device to monitor fetal oxygen levels during labor, aiming to improve outcomes for mothers and babies while reducing the risk of birth injuries and healthcare costs.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

fetal pulse oximeterfetal monitoringfetal oxygen saturationnon-invasive monitoringfetal distress detectionlabor and deliveryfemtechmedical devicemedtechmaternal-fetal medicinebirthtechC-section reductionphotonic sensorFDA Breakthrough Devicepost-partum hemorrhageInvestigational Device ExemptionIDE

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Raydiant Oximetry Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Raydiant Oximetry Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2024
GrantSep 24, 2024
Series A ExtensionMay 28, 2024
Series BFeb 7, 2023
Series A ExtensionNov 2, 2021
Grant
Apr 22, 2021

Key People

Founding team and executive leadership

Michael Nagel

Chief Executive Officer

Executive Team

Neil Ray

CEO Founder

Founding Team

Russ DeLonzor

President And Chief Operating Officer

Executive Team

Raydiant Oximetry Investors

Notable investors and investment history

Raydiant Oximetry Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Raydiant Oximetry Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Raydiant Oximetry's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Ramon, California
Employee Range25
Year Founded2016
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.